NCT07222800 2026-01-30
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Pfizer
Phase 3 Recruiting
Clinical Trials
86 trialsNCT05443321 2026-01-23
Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes
Brigham and Women's Hospital
Phase NA Enrolling by invitation
NCT04457297 2026-01-21
ALTAIR
National Cancer Center Hospital East
Phase 3 Completed
NCT07313579 2026-01-13
G-PEC
Ukrainian Society of Clinical Oncology
Recruiting
NCT05489237 2025-11-17
First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors
IDRx Inc. - A GSK Company
Phase 1 Recruiting
NCT05053191 2025-09-19
Advancing Nursing Practices in Hospital Oncology Care
Memorial Sloan Kettering Cancer Center
Phase NA Active not recruiting
NCT02246725 2025-09-12
ALLAN
Lund University Hospital
Completed
NCT03284879 2025-09-08
Post-Marketing Surveillance Study of OTEZLA
Amgen
Completed
NCT05101382 2025-08-24
ALFAOMEGA-R
IFOM ETS - The AIRC Institute of Molecular Oncology
Recruiting
NCT05655494 2025-08-24
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
University of Florida
Recruiting
NCT04607421 2025-08-14
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer
Pfizer
Phase 3 Active not recruiting
NCT03093116 2025-07-10
TRIDENT-1
Turning Point Therapeutics, Inc.
Phase 1/2 Recruiting
NCT06848400 2025-07-09
Capsule Gastric Endoscopy for Gastric Disease Screening in Simulated Home Scenarios
Nanfang Hospital, Southern Medical University
Phase NA Recruiting
NCT03037385 2025-05-31
ARROW
Hoffmann-La Roche
Phase 1/2 Completed
NCT01550510 2025-05-06
Research Study of IV Vitamin C in Combination With Irinotecan vs Irinotecan Alone for Advanced Colorectal CA
Thomas Jefferson University
Phase 1/2 Terminated
NCT04774952 2025-04-15
Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors
Revolution Medicines, Inc.
Phase 1 Completed
NCT06881043 2025-03-18
STARS-GC09
The First Hospital of Jilin University
Recruiting
NCT06560879 2025-03-14
Effectiveness of Probiotics for the Prevention of Gastrointestinal Toxicity in Children with Leukemia
National Institute of Pediatrics, Mexico
Phase 2 Enrolling by invitation
NCT01034670 2024-06-26
Advanced Gastrointestinal Endoscopic Imaging
Stanford University
Phase NA Terminated
NCT05160168 2024-06-05
A Study of THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
Theseus Pharmaceuticals
Phase 1/2 Terminated
NCT02831556 2024-05-21
Point of Care 3D Ultrasound for Various Applications: A Pilot Study
Duke University
Completed
NCT00838578 2024-04-26
Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer
Kyowa Kirin Co., Ltd.
Phase 1/2 Terminated
NCT03951792 2024-04-18
Time Longitudinal Study of the Microbiome in Colorectal Cancer Subjects
Mayo Clinic
Completed
NCT06365866 2024-04-15
Evaluate the Efficacy of Adding Intraluminal Brachytherapy After CCRT for Local-regional Thoracic Esophageal Cancer.
Taipei Veterans General Hospital, Taiwan
Phase NA Recruiting
NCT03549494 2024-02-07
Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction
Catalysis SL
Phase 2 Completed
NCT03559543 2024-02-07
Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma
Catalysis SL
Phase 2 Completed
NCT06236594 2024-02-01
Endo-mmfi
Beijing 302 Hospital
Unknown
NCT05579444 2023-12-15
Systems Biology of Gastrointestinal and Related Diseases
Viome
Terminated
NCT02753127 2023-11-15
CanStem303C
Sumitomo Pharma America, Inc.
Phase 3 Completed
NCT05494060 2023-11-07
EXPLORING
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Recruiting
NCT05051358 2023-05-26
TEUS Registry
Advanced Endoscopy Research, Robert Wood Johnson Medical School Rutgers University
Unknown
NCT03602677 2023-03-27
ICG-COLORAL
Oulu University Hospital
Phase NA Unknown
NCT04949282 2022-12-23
SEPTRALU
Sociedad Española de Medicina Nuclear e Imagen Molecular
Recruiting
NCT05252078 2022-12-16
ALTER-E005
Jiangxi Provincial Cancer Hospital
Phase 2 Recruiting
NCT03641118 2022-11-01
Sarcopenia and Physiology Assessments in Cancer Patients
University Hospital Southampton NHS Foundation Trust
Unknown
NCT03634982 2022-09-01
Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors
Revolution Medicines, Inc.
Phase 1 Unknown
NCT04080843 2022-07-13
ALTER-C-002
Zhejiang University
Phase 2 Completed
NCT03637647 2022-04-13
CPET and Outcome After Oesophagogastric Cancer Surgery
University Hospital Southampton NHS Foundation Trust
Completed
NCT05322486 2022-04-11
Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases
State Scientific Centre of Coloproctology, Russian Federation
Unknown
NCT02322593 2021-12-20
SOLAR
Taiho Pharmaceutical Co., Ltd.
Phase 3 Completed
NCT03025152 2021-04-26
Efficacy and Safety of Hou Gu Mi Xi in Patients With Spleen Qi Deficiency and Radical Gastrectomy for Gastric Cancer
Jiangxi University of Traditional Chinese Medicine
Phase NA Terminated
NCT03503162 2021-04-13
Evaluation of the Bowel Cleansing in Hospitalized Patients Using Pure-Vu System
Motus GI Medical Technologies Ltd
Phase NA Completed
NCT01966289 2021-03-30
SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Completed
NCT03723447 2021-02-17
TINGLE
Cedars-Sinai Medical Center
Phase 4 Completed
NCT02981524 2021-02-10
Study of GVAX (With CY) and Pembrolizumab in MMR-p Advanced Colorectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT04287335 2020-12-08
CLEAR-C
Zhejiang University
Completed
NCT01681472 2020-09-25
PK/PD Investigation of Modufolin (Arfolitixorin) in Plasma, Tumor and Adjacent Mucosa Adjacent Mucosa in Patients With Colon Cancer
Isofol Medical AB
Phase 1/2 Completed
NCT01397305 2020-09-09
An Extended Feasibility Phase I/II Study of Methylenetetrahydrofolate (Arfolitixorin) and Pemetrexed Single Agent, Given as Neoadjuvant Treatment in Patients With Resectable Rectal Cancer
Isofol Medical AB
Phase 1/2 Completed
NCT04285008 2020-06-25
RESCue
Motus GI Medical Technologies Ltd
Phase NA Withdrawn
NCT04401124 2020-05-27
Status of Management of Surgery in Beijing During COVID-19
Beijing Friendship Hospital
Unknown